Superoxide dismutase and neurological disorders

Area of Science:

• Biochemistry
• Neuroscience
• Pharmacology

Background:

• Superoxide dismutase (SOD) is a critical antioxidant enzyme in cells, defending against reactive oxygen species (ROS) and reactive nitrogen species (RNS).
• SOD catalyzes the conversion of superoxide radicals to oxygen and hydrogen peroxide, maintaining cellular redox balance.
• Oxidative stress, characterized by increased ROS, inflammation, and mitochondrial dysfunction, is implicated in neuronal loss in neurodegenerative diseases.

Purpose of the Study:

• To explore the role of Superoxide Dismutase (SOD) in cellular defense and its implications in neurodegenerative diseases.
• To review the therapeutic potential of SOD and its mimetics in combating oxidative stress-mediated neurological disorders.

Main Methods:

• Literature review of SOD's enzymatic activity and its role in cellular redox homeostasis.
• Analysis of clinical and genetic studies linking SOD gene mutations to neurodegenerative diseases.
• Examination of SOD mimetics as therapeutic agents for neurological conditions.

Main Results:

• Mutations in the SOD gene are directly correlated with neurodegenerative diseases such as ALS, HD, PD, and AD.
• Inhibitors of oxidative stress, including SOD mimetics, are considered promising therapeutic strategies.
• SOD mimetics like Metalloporphyrin Mn (II)-cyclic polyamines, Nitroxides, and Mn (III)-Salen complexes are utilized in treating neurological disorders.

Conclusions:

• Superoxide Dismutase (SOD) plays a vital role in protecting the central nervous system from oxidative damage.
• SOD mimetics represent a significant therapeutic avenue for neurodegenerative diseases driven by oxidative stress.
• Targeting oxidative stress through SOD and its analogs offers a promising approach for future disease management.